Protagonist Therapeutics
Price & Volume
Stats
See more52W Range | $33.31-$93.24 |
Market Cap | $5.3B |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $209.2M |
Revenue Growth (YoY) | 0.8% |
Gross Profit (12 Mos) | $209.2M |
Diluted EPS | $0.66 |
News
See moreYahoo Finance • 17 days ago
Protagonist Therapeutics Says Icotrokinra Showed 'Meaningful' Outcomes in Ulcerative Colitis Phase 2 Trial
Yahoo Finance • last month
Protagonist Therapeutics falls amid a report J&J deal price may be lower
Yahoo Finance • last month
J&J in talks to acquire Protagonist Therapeutics
Yahoo Finance • last month
Key deals this week: Protagonist Therapeutics, Bristol Myers, Novo Nordisk, Fifth Third Bancorp and more
About
CEO | Dr. Dinesh V. Patel Ph.D. |
CFO | Mr. Asif Ali |
Address | 7707 Gateway Boulevard, Newark, CA, United States, 94560 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 128 |
